Zacks.com featured highlights include Globus Medical, NetApp and Assurant

This week’s Zacks.com highlights focus on three U.S. stocks—Globus Medical (GMED), NetApp (NTAP) and Assurant (AIZ)—as “sales growth” picks amid ongoing market volatility. The article points to a mix of pressures on sentiment in 2026, including Fed policy uncertainty, elevated Treasury yields, renewed Middle East tensions, higher oil prices, inflation and tariff concerns, even as major indexes stay positive. Zacks argues revenue growth is a steadier measure than earnings alone, supporting operating leverage and durable cash flows when growth is recurring and resilient. GMED’s 2026 expected sales growth is 8.8%.